Advisors Preferred’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
VCM
DM
VPM
Advisors Preferred's CPRX Position: Q1 2026 in Review
Advisors Preferred opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 381,183 shares worth $9.44M. The stake represents 1.39% of the portfolio and ranks #19 among its holdings. This is a return to the name: Advisors Preferred previously reported a position in CPRX as recently as Q4 2024.
Advisors Preferred first reported a position in CPRX in Q4 2024 and has held it in 2 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Advisors Preferred held 381,183 shares of Catalyst Pharmaceutical worth $9.44M as of Q1 2026.
- Catalyst Pharmaceutical was a new Advisors Preferred position in Q1 2026.
- Catalyst Pharmaceutical made up 1.39% of Advisors Preferred's portfolio in Q1 2026, its #19 holding.
- Advisors Preferred first reported a position in Catalyst Pharmaceutical in Q4 2024 and has held it in 2 quarters since.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Advisors Preferred's 13F filing for Q1 2026, filed 5 May 2026.